30/11/201626/01/2024 Helix BioPharma Corp. Accelerates Escalation of L-DOS47 Dosing in the US Phase I Study admin 0 Comments
17/11/201626/01/2024 Helix BioPharma Corp. Announces Poster Presentation of L-DOS47 at the World Conference on Lung Cancer admin 0 Comments